The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
Jeffrey Dunn once thought science was just memorizing facts. Then, an inspiring teacher offered another viewpoint: Find answers to science’s open questions.
Jeffrey Dunn, MD
Multiple sclerosis specialist
Clinical Professor, Neurology & Neurological Sciences
Bio:
Jeffrey Dunn, MD, FAAN is Professor of Clinical Neurology and Division Chief of Clinical Neuroimmunology in the Department of Neurology and Neurosciences at Stanford University. His clinical focus is the care of men and women with Multiple Sclerosis, Neuromyelitis Optica, and other conditions in which the immune system disrupts the central nervous system to cause disease. His research employs a collaborative approach to identify biomarkers of disease status and potential therapeutic targets via translational research for novel drug development. Dr. Dunn has served as Principal Investigator in more than 20 clinical trials of new and emerging treatments for MS. Dr. Dunn is dedicated to medical education, serving as the Neurology Clerkship Director for the Stanford University School of Medicine, and as Fellowship Director for the Clinical Neuroimmunology Fellowship Program that seeks to train the next generation of leaders in Multiple Sclerosis. Dr. Dunn is an elected Fellow of the American Academy of Neurology. He has been awarded the prestigious Henry J. Kaiser Family Foundation Award for Excellence in Clinical Teaching, the Arthur Bloomfield Award in recognition of excellence in the teaching of clinical medicine, and the Lysia Forno Award for teaching excellence.
- 213 Quarry Road
- Palo Alto, CA 94304
- Phone: 650-723-6469
- 213 Quarry Road
- Palo Alto, CA 94304
- Phone: 650-723-6469
Practice Areas
Professional Education
- Board Certification: Neurology, American Board of Psychiatry and Neurology (1994)
- Residency: University of Washington Medical Center (1989) WA
- Internship: Eastern VA Medical School (1989) VA
- Medical Education: Temple University School of Medicine (1989) PA
- Residency, University of Washington, Neurology (1993)
- M.D., Temple University, Medicine (1989)
- B.A., Haverford College, French Literature (1983)
Honors & Awards
- Henry J. Kaiser Family Foundation Award for Excellence in Clinical Teaching, Stanford University School of Medicine (2013)
- Top Doctors, US News & World Report (2012-2013)
- AUPN Neurology national recuitment award, Association of University Professors of Neurology (2012)
- Excellence in Teaching Award, Stanford University School of Medicine (2011-2012)
- AUPN Neurology Recruitment Award (highest percentage in U.S.), Association of University Professors of Neurology (2011)
- Arthur L. Bloomfield Award in Recognition of Excellence in the Teaching of Clinical Medicine, Stanford University School of Medicine (2011)
- Excellence in Teaching Award, Stanford University School of Medicine (2010-2011)
- Excellence in Teaching Award, Stanford University School of Medicine (2009-2010)
- Fellow, American Academy of Neurology (2008-present)
- Lysia K. Forno Award for Excellence in Teaching Neurology Residents, Stanford University Department of Neurology & Neurosciences (2008-2009)
- Excellence in Neurology Clerkship Teaching Award, Stanford University Department of Neurology & Neurosciences (2008,2009,2010,2011,2012,2013,2014,2015)
- "America's Top Rated Physicians", Guide to Top Doctors (1998-2007, 2010-2015)
Administrative Appointments
- Division Chief, Clinical Neuroimmunology, Department of Neurology & Neurological Sciences, Stanford Healthcare (2009 - Present)
- Neurology Clerkship Director, Stanford University School of Medicine (2009 - Present)
- Fellowship Director, Clinical Neuroimmunology Fellowship Program; Stanford University (2010 - 2016)
- Vice Chair, Multiple Sclerosis Section; American Academy of Neurology (2014 - 2016)
Publications
-
IFN-beta Treatment Requires B Cells for Efficacy in Neuroautoimmunity
Schubert, R. D., Hu, Y., Kumar, G., Szeto, S., Abraham, P., & Axtell, R. C. (2015). IFN-beta Treatment Requires B Cells for Efficacy in Neuroautoimmunity. JOURNAL OF IMMUNOLOGY, 194(5), 2110-2116. -
Mobility Concerns in Multiple Sclerosis
Lee, J.- mi, & Dunn, J. (2013). Mobility Concerns in Multiple Sclerosis. US Neurology, 9(1). -
Disease modifying therapies for non relapsing Multiple Sclerosis
Dunn, J. (2013). Disease modifying therapies for non relapsing Multiple Sclerosis. Neurol Clin Pract, December(3). -
Randomized study combining interferon and glatiramer acetate in Multiple Sclerosis
Lublin, F., & CombiRx Investigators. (2013). Randomized study combining interferon and glatiramer acetate in Multiple Sclerosis. Annals of Neurology, 73(3).
-
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein
Herges, K., de Jong, B. A., Kolkowitz, I., Dunn, C., Mandelbaum, G., & Axtell, R. C. (2012). Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. MULTIPLE SCLEROSIS JOURNAL, 18(4), 398-408.
-
Protective Effect of elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin olidodendrocyte glycoprotein
Herges K, DeJong BA, Kolkowitz I, Dunn C, Mandelbaum G, & Axtell RC. (2012). Protective Effect of elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin olidodendrocyte glycoprotein. Multiple Sclerosis, 18(4).
-
Alemtuzumab for patients with relapsing Multiple Sclerosis after disease modifying therapy: a randomized controlled Phase 3 trial.
A, C. J., & CARE MS II, I. (2012). Alemtuzumab for patients with relapsing Multiple Sclerosis after disease modifying therapy: a randomized controlled Phase 3 trial. Lancet, Nov 24(380).
-
Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis
Dunn, J., & Blight, A. (2011). Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis. CURRENT MEDICAL RESEARCH AND OPINION, 27(7), 1415-1423.
-
Dalfampridine: A brief review of its Mechanism of Action and Efficacy as a treatment to improve walking in patients with Multiple Sclerosis
Dunn J, & Blight A. (2011). Dalfampridine: A brief review of its Mechanism of Action and Efficacy as a treatment to improve walking in patients with Multiple Sclerosis. Current Research Medical Opinion, 27(7).
-
Impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis
Dunn, J. (2010). Impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 10(4), 433-440.
-
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
Wynn, D., Kaufman, M., Montalban, X., Vollmer, T., Simon, J., & Rose, J. W. (2010). Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. LANCET NEUROLOGY, 9(4), 381-390.
-
The impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis
Dunn, J. (2010). The impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis. Expert Rev. Pharmacoeconomics Outcomes Res., 10(4).
-
Cytomegalovirus Infection with MRI Signal Abnormalities Affecting the Optic Nerves, Optic Chiasm, and Optic Tracts
Pershing, S., Dunn, J., Khan, A., & Liao, Y. J. (2009). Cytomegalovirus Infection with MRI Signal Abnormalities Affecting the Optic Nerves, Optic Chiasm, and Optic Tracts. JOURNAL OF NEURO-OPHTHALMOLOGY, 29(3), 223-226.
-
CMV Optic Neuritis with Extensive Tracking along the Visual Pathway
Pershing S, D. J. K. A. L. Jy. (2009). CMV Optic Neuritis with Extensive Tracking along the Visual Pathway. J Neuro-Ophthalmology, 29(3).
-
Glatiramer Acetate after Induction Therapy with Mitoxantrone in Relapsing Multiple Sclerosis
Vollmer T, P. H. B.-O. A. D. J. F. Ms. G. Sk. C. D. D. F. A. D. (2008). Glatiramer Acetate after Induction Therapy with Mitoxantrone in Relapsing Multiple Sclerosis. Multiple Sclerosis, Apr 18.
-
Tovaxin for Early Relapsing Multiple Sclerosis Phase 2b Placebo Controlled Trial of Autologous T cell vaccination in patients with CIS or RRMS
Fox, Ej., & The TERMS Study Investigators. (2008). Tovaxin for Early Relapsing Multiple Sclerosis Phase 2b Placebo Controlled Trial of Autologous T cell vaccination in patients with CIS or RRMS. Multiple Sclerosis, 14.
-
Glatiramer Acetate after Mitoxantrone Induction improves MRI markers of lesion volume and permanent tissue injury in MS
Arnold D., C. D. P. H. B.-O. A. D. J. F. M. G. S. K. V. T. (2008). Glatiramer Acetate after Mitoxantrone Induction improves MRI markers of lesion volume and permanent tissue injury in MS. J Neurol, 255.
-
Daclizumab in Patients with Active Relapsing Multiple Sclerosis on Concurrent Interferon beta Therapy; Week 24 data Phase II
Montalban X, K. M. W. D. et D. J. with the Choice. S. I. (2007). Daclizumab in Patients with Active Relapsing Multiple Sclerosis on Concurrent Interferon beta Therapy; Week 24 data Phase II. ECTRIMS, 10/11/07.
-
Randomized, Double Blind, Dose Comparison Study of Glatiramer Acetate in Relapsing Remitting MS
Cohen JA Rovaris M Goodman AD Ladkani D Wynn D Filippi M 9006 Study Group. (2007). Randomized, Double Blind, Dose Comparison Study of Glatiramer Acetate in Relapsing Remitting MS. Neurology, 68(12).
-
Safety and Tolerability of Glatiramer Acetate in Pediatric Patients with Relapsing Remitting Multiple Sclerosis
Krupp L, B. B. P. M. D. J. W.-G. B. P. L. (2005). Safety and Tolerability of Glatiramer Acetate in Pediatric Patients with Relapsing Remitting Multiple Sclerosis. ECTRIMS/ACTRIMS, (September).
-
Novantrone in the Treatment of Multiple Sclerosis
Dunn Jeffrey, K. M. L. S. B. J. (2001). Novantrone in the Treatment of Multiple Sclerosis. Alliance News.
-
Comprehensive Outpatient Management of Patients with Multiple Sclerosis
Odderson I, D. J. (2001). Comprehensive Outpatient Management of Patients with Multiple Sclerosis. RIMS MS Symposium, (May).
-
Clinical Advisory Committee Statement
Bowen J., D. J. E. K. G. H. R. G. S. J. S. C. T. L. (1999). Clinical Advisory Committee Statement. Health Care Connection, I(1).
-
Gingko Biloba in the Treatment of Alzheimer's Disease
Dunn Jeffrey E., M. R. P. J. (1998). Gingko Biloba in the Treatment of Alzheimer's Disease. Alternative Medicine, 1(15).
-
Atherosclerotic Aortic Disease as a Source of Embolic Infarct
Bursell John P., O. I. D. J. E. (1996). Atherosclerotic Aortic Disease as a Source of Embolic Infarct. Journal of Neurovascular Disease, 1(2).
-
INTRACEREBRAL BACILLARY ANGIOMATOSIS IN A PATIENT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Spach, D. H., Panther, L. A., Thorning, D. R., Dunn, J. E., Plorde, J. J., & MILLER, R. A. (1992). INTRACEREBRAL BACILLARY ANGIOMATOSIS IN A PATIENT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS. ANNALS OF INTERNAL MEDICINE, 116(9), 740-742.
-
Intracerebral Bacillary Angiomatosis in a Patient Infected with HIV
Spach, D., Panther L., Thorning D., Dunn Jeffrey E., Plorde J.L., & R. (1992). Intracerebral Bacillary Angiomatosis in a Patient Infected with HIV. Annals of Internal Medicine, 116.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Mar 2016
Dr. Dunn is by far one of the best medical professionals with. He is very attentive and genuinely cares about the welfare of his patients.
SHC Patient, Feb 2016
Caring explanations given.
SHC Patient, Feb 2016
Doctors Kipp & Dunn were both very professional, respectful, & extremely knowledgeable. I learned more about my condition & how it related to me personally during this visit than the previous 1.5 yrs. seeing other providers.
SHC Patient, Feb 2016
awesome doctor and staff
SHC Patient, Jan 2016
Good.
SHC Patient, Dec 2015
Dr. Dunn is an incredible, sweet doctor, could not find a better man to take care of me.
SHC Patient, Dec 2015
I remain very happy with Dr. Dunn's service & care.
SHC Patient, Dec 2015
Dr. Dunn is one of Stanford's better doctors.
SHC Patient, Nov 2015
Dr Dunn is the best doctor I have ever seen, knowledgeable, friendly, and sincerely concern about my wellness.
SHC Patient, Nov 2015
Dr. Dunn was thorough & kind.
SHC Patient, Oct 2015
Dr. Dunn is wonderful. He is patient and explained everything in lay terms. I understood what was wrong and next steps.
SHC Patient, Oct 2015
IN MY 35+ YEARS OF SEEING NUEROLOGY DOCTORS DR. DUNN IS ONE OF THE BEST. HE REALLY CARES ABOUT TREATING THE WHOLE PERSON NOT JUST THE MS. I WOULD HIGHLY RECOMMEND HIM TO ANYONE.
SHC Patient, Oct 2015
I love Dr. Dunn my husband & I COULD NOT find better care for me - Total trust in Jeff Dunn!! - Perfection.
SHC Patient, Oct 2015
Dr. Dunn is thorough, professional and easy to talk to.
SHC Patient, Jul 2015
Dr. Dunn is fantastic! I have referred a number of people to him.
SHC Patient, Jul 2015
Dr. Dunn provided me with an accurate diagnosis to my debilitating disease after several hours researching.
SHC Patient, Jul 2015
Kindest dr. I've ever encountered.
SHC Patient, Jun 2015
Dr. Dunn is the most astonishingly wonderful physician I've ever met with in my 46 years on the planet. This was my first office visit with him. I have never been so impressed in my life. He is clearly at the top of his field. His bedside manner is an "11" on a scale of 1-10. I did not feel rushed. I felt his concern for me was genuine. He is amazing.
SHC Patient, Jun 2015
Love Dr. Dunn! He's awesome.
SHC Patient, May 2015
He is very, very good.
SHC Patient, Apr 2015
I was very impressed with Dr.'s Dunn, Shum, & Sherman.
SHC Patient, Mar 2015
Dr. Dunn is the BEST! His attitude and empathy always makes me feel positive about my condition when I leave the office.
SHC Patient, Dec 2014
Dr. Dunn listens carefully, answers questions thoroughly and instills great confidence that my health and well being are WELL addressed. I couldn't ask for a better doctor.
SHC Patient, Sep 2014
Dr. Dunn always explains my problems in detail - (a great person/doctor.
SHC Patient, Aug 2014
The care and compassion that Dr. Dunn shared with me (and my husband) was very much appreciated!! Thank you.
SHC Patient, Jul 2014
Great doctor!
SHC Patient, Jul 2014
Dr. Dunn & his staff are the ultimate professionals. They are very caring and comforting. They encourage me and give me hope -
SHC Patient, Jul 2014
Again - I just wish we could have seen images at initial visit instead had to come back for follow up which was very inconvenient.
SHC Patient, Jun 2014
Dr. Dunn is an outstanding doctor and I am fortunate to be able to be under his care.
SHC Patient, May 2014
Dr. Dunn was fantastic! He spent more time with me and I never felt he was rushed. Very thorough. Superb clinical acumen.
SHC Patient, May 2014
Dr. Dunn is very good at what he does.
SHC Patient, May 2014
Dr. Dunn was very informative, thoughtful, and sincere.
SHC Patient, Mar 2014
Wonderful doc - knows his stuff - very kind - he is wroth the wait.
SHC Patient, Mar 2014
Jeff Dunn is the best doctor - absolute trust in him -
SHC Patient, Mar 2014
Dr. Dunn is very friendly and very good at explaining my condition to me.
SHC Patient, Feb 2014
Dr. Dunn is the best doctor ever!
SHC Patient, Dec 2013
I felt in the best of care -
SHC Patient, Dec 2013
Extremely good! Very respectful of me & my illness.
SHC Patient, Dec 2013
Excellent staff! Very clean office.
SHC Patient, Dec 2013
Dr. Dunn made me feel well taken care of. I slept well for the 1st time in many weeks after that appt.
SHC Patient, Mar 2016
Dr. Dunn is by far one of the best medical professionals with. He is very attentive and genuinely cares about the welfare of his patients.
SHC Patient, Feb 2016
Caring explanations given.
SHC Patient, Feb 2016
Doctors Kipp & Dunn were both very professional, respectful, & extremely knowledgeable. I learned more about my condition & how it related to me personally during this visit than the previous 1.5 yrs. seeing other providers.
SHC Patient, Feb 2016
awesome doctor and staff
SHC Patient, Jan 2016
Good.
SHC Patient, Dec 2015
Dr. Dunn is an incredible, sweet doctor, could not find a better man to take care of me.
SHC Patient, Dec 2015
I remain very happy with Dr. Dunn's service & care.
SHC Patient, Dec 2015
Dr. Dunn is one of Stanford's better doctors.
SHC Patient, Nov 2015
Dr Dunn is the best doctor I have ever seen, knowledgeable, friendly, and sincerely concern about my wellness.
SHC Patient, Nov 2015
Dr. Dunn was thorough & kind.
SHC Patient, Oct 2015
Dr. Dunn is wonderful. He is patient and explained everything in lay terms. I understood what was wrong and next steps.
SHC Patient, Oct 2015
IN MY 35+ YEARS OF SEEING NUEROLOGY DOCTORS DR. DUNN IS ONE OF THE BEST. HE REALLY CARES ABOUT TREATING THE WHOLE PERSON NOT JUST THE MS. I WOULD HIGHLY RECOMMEND HIM TO ANYONE.
View All 40 Patient Comments »